Mr. Potter receives an NIH F31 HL154571 training grant entitled: “Interrogating the role and regulation of EGR2 in the diabetic heart”.
Drs. Chatham, Wende Secure R21 to Study How O-GlcNAc Regulates Function of Healthy Heart
John C. Chatham, Ph.D., Professor, and Adam R. Wende, Ph.D., Associate Professor, in the Division of Molecular and Cellular Pathology, have been awarded a two-year, R21 grant from the National Heart, Lung and Blood Institute (NHLBI) to study the role of protein O-linked N-Acetylglucosamine in regulating cardiac physiology. Read full story here.
Wende Helps Put Blood Cancer on the Run
Dr. Wende uses his personal experiences to drive change for leukemia patients. Read the full story here.
Wende Awarded R01 for Cardiac DNA Remodeling
Dr. Wende receives his first NIH R01 HL133011 grant entitled: “Glucose-mediated remodeling of cardiac DNA methylation”.
